Private Advisor Group LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Private Advisor Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 92,882 shares of the healthcare conglomerate’s stock after purchasing an additional 2,528 shares during the period. Private Advisor Group LLC’s holdings in UnitedHealth Group were worth $47,707,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $4,478,185,000. Arrowstreet Capital Limited Partnership raised its position in shares of UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of UnitedHealth Group by 60.4% in the first quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock valued at $2,580,442,000 after buying an additional 1,886,128 shares during the last quarter. Capital Research Global Investors raised its position in shares of UnitedHealth Group by 8.3% in the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after buying an additional 1,482,338 shares during the last quarter. Finally, Invesco Ltd. raised its position in shares of UnitedHealth Group by 28.3% in the first quarter. Invesco Ltd. now owns 6,018,008 shares of the healthcare conglomerate’s stock valued at $3,069,002,000 after buying an additional 1,328,237 shares during the last quarter. 87.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on UNH. Credit Suisse Group raised their price objective on shares of UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Mizuho raised their price objective on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. UBS Group increased their target price on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Finally, Sanford C. Bernstein lowered shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $586.40.

UnitedHealth Group Stock Performance

Shares of UNH opened at $517.46 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. The stock has a market capitalization of $484.02 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The company’s fifty day moving average is $530.11 and its two-hundred day moving average is $512.45. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s revenue was up 12.6% on a year-over-year basis. During the same period in the previous year, the firm earned $4.70 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a $1.65 dividend. The ex-dividend date was Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is presently 34.46%.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 465 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Andrew Witty sold 11,376 shares of the stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is owned by insiders.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.